Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
Clinical trial NCT04593251 · COMPLETED
Trial details
- NCT number
- NCT04593251
- Sponsor
- Calypso Biotech BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2024-04-02
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.